Results 191 to 200 of about 85,956 (353)

Chronic Pulsatile Low Dose GnRH Therapy for Induction of Testosterone Production and Spermatogenesis in a Man with Secondary Hypogonadotropic Hypogonadism* [PDF]

, 1982
Göran Skarin, Sven Johan Nillius, L Wibell, Leif Wide   +3 more
openalex   +1 more source

Testicular Function After Immune‐Checkpoint Inhibitors Treatment

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To investigate the effects of immune‐checkpoint inhibitors (ICIs) on spermatogenesis and testicular endocrine function in reproductive‐age men with melanoma. Design Prospective, mixed longitudinal and cross‐sectional cohort study. Patients Twenty‐nine men aged 19–46 years undergoing ICI therapy for melanoma at two Australian centres ...
Andrea Boutros, Amanda Idan, Sue Sleiman, Feyrous Bacha, Ting Zhang, Veena Jayadev, Alexander M. Menzies, Georgina V. Long, David J. Handelsman   +8 more
wiley   +1 more source

The frequency and peculiarities of hypogonadism in men with obesity

Ожирение и метаболизм
BACKGROUND: Male hypogonadism is associated with obesity, therefore, it is of interest to study its frequency. The clinical symptoms of hypogonadism are not specific, and laboratory diagnostics is the basis for its detection.
R. V. Rozhivanov, E. V. Morozova, V. A. Ioutsi, M. A. Antsupova, L. V. Savelyeva, E. R. Rozhivanova, E. N. Andreeva, G. A. Mel’nichenko, N. G. Mokrysheva   +8 more
doaj   +1 more source

Hypogonadism and life-long anosmia

, 1966
T. D. R. Hockaday
openalex   +1 more source

IMPROVE 2023: The 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence

Clinical Obesity, EarlyView.
ABSTRACT A total of 150 clinicians and researchers representing 19 countries came together in person and online to participate in the highly anticipated 2nd International Meeting on Pathway‐Related Obesity: Vision & Evidence (IMPROVE), held on 13–15 December 2023 in Paris, France.
Karine Clément, Erica L. T. van den Akker, Jesús Argente, Phil Beales, Metin Cetiner, Béatrice Dubern, Sadaf Farooqi, Aurélie Gouronc, Peter Kühnen, Johanne Le Beyec, Louis Lebreton, David Meeker, Hermann L. Müller, Jean Muller, Christine Poitou, Patrick Sleiman, Christian Vaisse, Martin Wabitsch, Jacques Young, Hélène Dollfus   +19 more
wiley   +1 more source

Villous adenoma of the rectum with electrolyte depletion, diabetes and hypogonadism

, 1965
Jennifer Bamford, H-J. B. Galbraith, B.W.T. Pender   +2 more
openalex   +1 more source

Hereditary ectodermal dysplasia, olivopontocerebellar degeneration, short stature, and hypogonadism. [PDF]

, 1981
Alan R. Rushton, Myron Genel
openalex   +1 more source

Paediatric and adult-onset male hypogonadism

Nature Reviews Disease Primers, 2019
A. Salonia, G. Rastrelli, G. Hackett, S. Seminara, I. Huhtaniemi, R. Rey, W. Hellstrom, M. Palmert, G. Corona, G. Dohle, M. Khera, Yee-Ming Chan, M. Maggi   +12 more
semanticscholar   +2 more sources

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

Cell Proliferation, EarlyView.
CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri   +4 more
wiley   +1 more source

GONADOTROPHIN RESPONSES TO GnRH PULSES IN HYPOGONADOTROPHIC HYPOGONADISM: LH RESPONSIVENESS IS MAINTAINED IN THE PRESENCE OF LUTEAL PHASE CONCENTRATIONS OF OESTROGEN AND PROGESTERONE [PDF]

, 1987
Todd B. Nippoldt, Sleman Khoury, Ariel L. Barkan, Robert P. Kelch, John C. Marshall   +4 more
openalex   +1 more source